Quantcast
Last updated on April 19, 2014 at 1:20 EDT

Latest Ketones Stories

2014-03-11 16:26:19

PITTSBURGH, March 11, 2014 /PRNewswire/ -- Mylan Inc. (Nasdaq: MYL) today announced that it has launched Naloxone Hydrochloride Injection USP, 0.4 mg/mL packaged in 1 mL single-dose vials. Mylan's product was determined to be bioequivalent and, therefore, therapeutically equivalent to the reference listed drug, Naloxone Hydrochloride Injection 0.4 mg/mL, of Hospira Inc. Naloxone Hydrochloride Injection is indicated for the complete or partial reversal of opioid depression, including...

2014-03-07 08:26:19

Two-thirds of states include methadone on preferred drug lists for Medicaid patients PHOENIX, March 7, 2014 /PRNewswire-USNewswire/ -- Two-thirds of states prefer methadone above other opioid medications to treat chronic pain, particularly in low-income residents, a practice top pain physicians say adds unnecessary risk. Physician leaders from the American Academy of Pain Medicine (AAPM) released a position paper today to warn all states and private insurers that methadone should...

2014-03-06 20:21:55

Researchers sought comprehensive predictors of opioid abuse in veterans based on discontinuation rates PHOENIX, March 6, 2014 /PRNewswire-USNewswire/ -- Of nearly 1 million veterans who receive opioids to treat painful conditions, more than half continue to consume opioids chronically or beyond 90 days, new research says. Results presented at the 30(th) Annual Meeting of the American Academy of Pain Medicine reported on a number of factors associated with opioid discontinuation with...

2014-03-05 23:30:09

Dr. Dominick Angiolillo begins clinical study of rapid CYP2C19 genotyping in Jacksonville. Ottawa, Ontario (PRWEB) March 05, 2014 Spartan Bioscience today announced the start of a study of personalized medicine at the University of Florida. The Spartan RX CYP2C19 System is being used to test heart attack patients receiving cardiac stents. The study is entitled “A Pharmacodynamic Study Comparing Prasugrel Versus Ticagrelor in Patients Undergoing PCI With CYP2C19 Loss-of-function...

2014-03-05 14:40:37

Although some research has suggested that the use of the anticoagulant warfarin for atrial fibrillation among patients with chronic kidney disease would increase the risk of death or stroke, a study that included more than 24,000 patients found a lower l-year risk of the combined outcomes of death, heart attack or stroke without a higher risk of bleeding, according to a study in the March 5 issue of JAMA. Juan Jesus Carrero, Ph.D., of the Karolinska Institutet, Stockholm, and colleagues...

2014-03-04 23:20:36

Success rate of Sunrise Nutraceuticals' new opiate withdrawal detox formula reveals product that works exceptionally well for users. Dallas, TX (PRWEB) March 04, 2014 Several months after its much-anticipated release, Sunrise Nutraceuticals’ one-of-a-kind opiate withdrawal support supplement continues to impress. As the Elimidrol reviews pour in, feedback has been overwhelmingly positive—a strong indicator of the supplement’s effectiveness, and excellent news for those...

2014-03-04 12:26:45

The death of actor Philip Seymour Hoffman from a heroin overdose has generated discussion regarding medical treatment to prevent heroin deaths. Suboxone (Buprenorphine/Naloxone) is a medication that is used to treat addiction to heroin and other narcotic painkillers. NEW YORK, March 4, 2014 /PRNewswire/ -- The death of actor Philip Seymour Hoffman from a heroin overdose has generated discussion regarding medical treatment to prevent heroin deaths. Buprenorphine is a medication used...

2014-03-04 08:32:42

Composition of Matter Patents Issued in Multiple Countries for KemPharm's Lead Abuse-Deterrent Hydrocodone Prodrug CORALVILLE, Iowa, March 4, 2014 /PRNewswire/ -- KemPharm, Inc., a clinical stage biopharmaceutical company focused on the discovery and development of new, safer therapies to treat pain, announced today that multiple global composition of matter patents have been issued for KP201 in Russia, Ukraine, Kazakhstan, Japan, Australia, New Zealand and South Africa....

2014-02-27 16:22:46

DUBLIN, February 27, 2014 /PRNewswire/ -- Dublin - Research and Markets ( http://www.researchandmarkets.com/research/xmqllc/hexafluoroacetone) has announced the addition of the "Hexafluoroacetone (CAS 684-16-2) Market Research Report 2013" [http://www.researchandmarkets.com/research/xmqllc/hexafluoroacetone ] report to their offering. (Logo: http://photos.prnewswire.com/prnh/20130307/600769 ) Hexafluoroacetone (CAS 684-16-2) Market Research Report presents...

Zohydro FDA Approval Sparks Concerns From Several Groups
2014-02-26 13:58:12

Lee Rannals for redOrbit.com - Your Universe Online A group of 40 organizations have joined together to try and influence the Food and Drug Administration (FDA) to revoke its approval of the prescription drug Zohydro. The group of health care professionals and consumer and addiction treatment groups say they are “echoing the concerns” of members of Congress and the State Attorneys General regarding the FDA’s decision to approve Zohydro for use. “On behalf of consumer safety...